Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Levormeloxifene preclinical and clinical data presented

Sep. 22, 1997

Additional PLAs filed for INVICORP

Sep. 22, 1997

Eel calcitonin nasal spray evaluated in phase I

Sep. 22, 1997

Calcimimetic agent shown active in preclinical models of hyperparathyroidism

Sep. 22, 1997

Tiqueside inhibits cholesterol absorption and reduces LDL cholesterol in humans

Sep. 19, 1997

OGS compound for glycolipid storage disorders nears clinic

Sep. 19, 1997

GH secretagogues for osteoporosis

Sep. 19, 1997

PTH analogue restores bone mass in rabbits with glucocorticoid-induced osteopenia

Sep. 19, 1997

Lilly describes another SERM derived from raloxifene

Sep. 19, 1997

Mitsubishi comes up with a new conjugate of 17beta-estradiol and a bisphosphonate

Sep. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.